Effect of prednisolone and saireito co-administration on T-cells of rheumatoid arthritis patients.

Yamazaki, Kyosuke; Kiyomi, Anna; Imai, Shinobu; Sugiyama, Kentaro; Tahara, Koichiro; Sawada, Tetsuji; Sugiura, Munetoshi

Yamazaki, Kyosuke; Kiyomi, Anna; Imai, Shinobu; Sugiyama, Kentaro; Tahara, Koichiro; Sawada, Tetsuji; Sugiura, Munetoshi.

Afiliação

Yamazaki K; Department of Drug Safety and Risk Management, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan. y141193@toyaku.ac.jp.
Kiyomi A; Department of Drug Safety and Risk Management, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Imai S; Department of Drug Safety and Risk Management, Tokyo University of Pharmacy and Life Sciences, and Division of Pharmacoepidemiology, Department of Healthcare and Regulatory Sciences, Showa University School of Pharmacy, Tokyo, Japan.
Sugiyama K; Department of Clinical Pharmacology, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Tahara K; Department of Rheumatology, Tokyo Medical University Hospital, Tokyo, Japan.
Sawada T; Department of Rheumatology, Tokyo Medical University Hospital, Tokyo, Japan.
Sugiura M; Department of Drug Safety and Risk Management, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

Clin Exp Rheumatol ; 41(9): 1777-1783, 2023 Sep.

Article em En | MEDLINE | ID: mdl-36826781

Assuntos

Antirreumáticos; Artrite Reumatoide; Adulto; Humanos; Prednisolona/efeitos adversos; Antirreumáticos/efeitos adversos; Leucócitos Mononucleares; Interleucina-6; Metotrexato/efeitos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos Limite: Adult / Humans Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google